A phase III clinical trial of MicroPine for myopia
Phase of Trial: Phase III
Latest Information Update: 09 Jul 2018
At a glance
- Drugs Atropine (Primary)
- Indications Myopia
- Focus Registrational; Therapeutic Use
- Sponsors Eyenovia
- 09 Jul 2018 According to an Eyenovia Inc. media release, the company is planning to initiate the trial in mid-2019.
- 09 May 2018 According to an Eyenovia Inc. media release, the company has received positive feedback from the US FDA to advance MicroPine for progressive pediatric myopia into Phase III development with possibility of only one trial required for registration.
- 28 Feb 2018 New trial record